Fluorescent biosensors for probing CDK4/cyclin D activity and developing non-ATP pocket Inhibitors for melanoma, lung cancer and lymphoma

被引：0
|
作者：
Morris, May [1 ]
Prevel, Camille [1 ]
Pellerano, Morgan [1 ]
Thi Nhu Ngoc Van [1 ]
机构：
[1] IBMM CNRS 5247, Montpellier, France
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
972.2
引用
收藏
页数：2
相关论文
共 31 条
  • [1] Design and synthesis of non-ATP competitive inhibitors of CDK4/Cyclin D using REPLACE
    Liu, Shu
    Premnath, Padmavathy Nandha
    Bolger, Joshua K.
    Estes, Kara
    McInnes, Campbell
    CANCER RESEARCH, 2011, 71
  • [2] New Strategies for Probing and Inhibiting CDK4/cyclin D Hyperactivity in Melanoma
    Prevel, Camille
    Pellerano, Morgan
    Bihel, Frederic
    Meunier, Laurent
    Morris, May
    FASEB JOURNAL, 2015, 29
  • [3] Novel ATP-site cyclin-dependent kinase (CDK) inhibitors: Selective inhibitors of CDK4/cyclin D.
    Li, L
    Chong, WKM
    Duvadie, RK
    Chu, SS
    Yang, YM
    Nonomiya, J
    Tucker, KD
    Lewis, CT
    Knighton, DR
    Ferre, RA
    Lundgren, K
    Koudriakova, T
    Escobar, J
    Price, SM
    Huber, A
    Sisson, W
    Aust, RM
    Verkhivker, GM
    Schaffer, L
    Rose, PW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U985 - U986
  • [4] Structure-activity relationships (SAR) for human cyclin-dependent kinase 4 (CDK4)/cyclin D with hovel CDK inhibitors using a CDK4 homology model.
    Schaffer, L
    Rose, PW
    Chong, WKM
    Li, L
    Duvadie, RK
    Nonomiya, J
    Knighton, DR
    Ferre, R
    Yang, YM
    Chu, SS
    Tucker, KD
    Sisson, W
    Aust, RM
    Lewis, CT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U530 - U530
  • [5] Fluorescent peptide biosensor for monitoring CDK4/cyclin D kinase activity in melanoma cell extracts, mouse xenografts and skin biopsies
    Prevel, Camille
    Pellerano, Morgan
    Gonzalez-Vera, Juan A.
    Henri, Pauline
    Meunier, Laurent
    Vollaire, Julien
    Josserand, Veronique
    Morris, May C.
    BIOSENSORS & BIOELECTRONICS, 2016, 85 : 371 - 380
  • [6] Anticancer activity of britannin through the downregulation of cyclin D1 and CDK4 in human breast cancer cells
    Hamzeloo-Moghadam, Maryam
    Aghaei, Mahmoud
    Abdolmohammadi, Mohammad Hossein
    Fallahian, Faranak
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (05) : 1105 - 1108
  • [7] Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
    Zijie Cai
    Jingru Wang
    Yudong Li
    Qianfeng Shi
    Liang Jin
    Shunying Li
    Mengdi Zhu
    Qi Wang
    Lok Lam Wong
    Wang Yang
    Hongna Lai
    Chang Gong
    Yandan Yao
    Yujie Liu
    Jun Zhang
    Herui Yao
    Qiang Liu
    Science China Life Sciences, 2023, 66 : 94 - 109
  • [8] Overexpressed cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
    Liu, Qiang
    Cai, Zijie
    Wang, Jingru
    Li, Yudong
    Wong, Lok Lam
    CANCER RESEARCH, 2022, 82 (04)
  • [9] Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
    Cai, Zijie
    Wang, Jingru
    Li, Yudong
    Shi, Qianfeng
    Jin, Liang
    Li, Shunying
    Zhu, Mengdi
    Wang, Qi
    Wong, Lok Lam
    Yang, Wang
    Lai, Hongna
    Gong, Chang
    Yao, Yandan
    Liu, Yujie
    Zhang, Jun
    Yao, Herui
    Liu, Qiang
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (01) : 94 - 109
  • [10] Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
    Zijie Cai
    Jingru Wang
    Yudong Li
    Qianfeng Shi
    Liang Jin
    Shunying Li
    Mengdi Zhu
    Qi Wang
    Lok Lam Wong
    Wang Yang
    Hongna Lai
    Chang Gong
    Yandan Yao
    Yujie Liu
    Jun Zhang
    Herui Yao
    Qiang Liu
    Science China(Life Sciences), 2023, 66 (01) : 94 - 109
1234